Developmental and physiological impacts of pathogenic human huntingtin protein in the nervous system
Tadros A. Hana, Veronika G. Mousa, Alice Lin, Rawan N. Haj-Hussein, Andrew H. Michael, Madona N. Aziz, Sevinch U. Kamaridinova, Sabita Basnet, Kiel G. OrmerodiD
Abstract
Huntingtons Disease (HD) is a neurodegenerative disorder, part of the nine identified inherited polyglutamine (polyQ) diseases. Most commonly, HD pathophysiology manifests in middle-aged adults with symptoms including progressive loss of motor control, cognitive decline, and psychiatric disturbances. Associated with the pathophysiology of HD is the formation of insoluble fragments of the huntingtin protein (htt) that tend to aggregate in the nucleus and cytoplasm of neurons. To track both the intracellular progression of the aggregation phenotype as well as the physiological deficits associated with mutant htt, two constructs of human HTT were expressed with varying polyQ lengths, non-pathogenic-htt (Q15, NP-htt) and pathogenic-htt (Q138, P-htt), with an N-terminal RFP tag for in vivo visualization. P-htt aggregates accumulate in the ventral nerve cord cell bodies as early as 24 hours post hatching and significant aggregates form in the segmental nerve branches at 48 hours post hatching. Organelle trafficking up-and downstream of aggregates formed in motor neurons showed severe deficits in trafficking dynamics. To explore putative downstream deficits of htt aggregation, ultrastructural changes of presynaptic motor neurons and muscles were assessed, but no significant effects were observed. However, the force and kinetics of muscle contractions were severely affected in P-htt animals, reminiscent of human chorea. Reduced muscle force production translated to altered locomotory behavior. A novel HD aggregation model was established to track htt aggregation throughout adulthood in the wing, showing similar aggregation patterns with larvae. Expressing P-htt in the adult nervous system resulted in significantly reduced lifespan, which could be partially rescued by feeding flies the mTOR inhibitor rapamycin. These findings advance our understanding of htt aggregate progression as well the downstream physiological impacts on the nervous system and peripheral tissues.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- FWCI
- 0.70
- Field percentile
- top 33%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pathogenic human huntingtin expression causes prolific intramuscular aggregation, leading to nuclear, metabolic, and physiological dysregulation in striated muscle.
Tadrs A. Hana, Kiel G. Ormerod·bioRxiv·Apr 22, 2026
- Huntingtin polyglutamine expansions misdirect axonal transport by perturbing motor and adaptor recruitment
Emily N. P. Prowse, Brooke A. Turkalj, … Adam G. Hendricks·iSciencePeer-reviewed·Apr 17, 2026
- Protective role of Pten downregulation in Huntington's Disease models
Nisha Nisha, Deepti Thapliyal, … Mayanglambam Dhruba Singh·bioRxiv·Mar 28, 2024
- Juvenile and adult expression of polyglutamine expanded huntingtin produce distinct aggregate distributions in Drosophila muscle
Taylor Barwell, Sehaj Raina, … Laurent Seroude·Human Molecular GeneticsPeer-reviewed·Jun 23, 2023
- mTOR inhibition in Q175 Huntington's disease model mice facilitates neuronal autophagy and mutant huntingtin clearance
Philip H. Stavrides, Chris N. Goulbourne, … Dun‐Sheng Yang·eLifePeer-reviewed·Jan 28, 2025
- Formation of amyloid-like HTTex1 aggregates in neurons, downregulation of synaptic proteins and early mortality of Huntington's disease flies are causally linked
Anne Ast, Leonard Roth, … Erich E. Wanker·bioRxiv·Feb 6, 2025